Clinical Trial

Evaluation of the Effectiveness of Odontogenic Grafts Obtained From Human Teeth on Bone Formation

Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated May 7, 2026 (before its estimated August 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Tooth extraction triggers a cascade of biological events mediated by the local inflammatory response following surgical intervention and by the loss of masticatory stimulation to the periodontium. These factors disrupt the homeostasis and structural integrity of the periodontal tissues. Following tooth loss, bone remodeling is initiated and continues for several months, with the majority of dimensional and morphological changes occurring within the first three months. This early alveolar bone resorption may compromise future implant placement and prosthetic rehabilitation. Previous studies by Schmidt-Schultz and Schultz have demonstrated that biologically intact growth factors can be preserved within the collagenous extracellular matrix of ancient human bone and teeth. These findings suggest that stored dentin may retain biologically active growth factors and provide regenerative benefits comparable to those of freshly prepared dentin, while eliminating the need for simultaneous multiple surgical interventions. Moreover, the volume of particulate dentin exceeds twice the original root volume, allowing for the acquisition of sufficient graft material for clinical application. Based on these biological and volumetric advantages, the use of autogenous stored mineralized dentin grafts (ASMDG) has emerged as a promising approach for alveolar socket preservation. ASMDG may contribute to limiting post-extraction alveolar ridge resorption and maintaining ridge dimensions during the critical early healing period.
Trial Details
NCT Number NCT07573761
Lead Sponsor Istanbul Saglik Bilimleri University
Conditions Alveolar Bone Loss, Periodontal Diseases, Periodontal Bone Loss, Periodontal Atrophy, Bone Diseases, Bone Resorption
Enrollment 21 participants
Start Date 2026-02-02
Primary Completion 2026-08-01 (estimated)
Study Completion 2026-09-01 (estimated)
Updated on ClinicalTrials.gov 2026-05-07